A new publication involving the peptide KPV appeared on October 7, 2026, in the journal Tissue & Cell. The study is titled "Lysine-Proline-Valine attenuates oxidized low-density lipoprotein-induced foam cell formation and inflammatory responses in RAW264.7 macrophages." This entry is indexed under PubMed ID 42854645. KPV remains classified as an unapproved compound used only in research settings. The publication record does not include findings or outcome summaries beyond its title. No results, conclusions, or data points were provided alongside this listing. Readers interested in the full scope of this study should consult the original source directly for details on methodology and outcomes. This brief reports only the existence and bibliographic details of the publication as listed. It does not characterize or interpret any results, since none were supplied in the event data. For general background on KPV, including its research classification and context, readers can refer to the compound overview.
New Publication on KPV in Tissue & Cell Journal
Source: https://pubmed.ncbi.nlm.nih.gov/42854645/